Provided by Tiger Fintech (Singapore) Pte. Ltd.

MaxCyte Inc

1.41
+0.05003.68%
Post-market: 1.410.00000.00%16:41 EDT
Volume:488.09K
Turnover:684.46K
Market Cap:150.32M
PE:-3.33
High:1.44
Open:1.35
Low:1.35
Close:1.36
52wk High:5.20
52wk Low:1.26
Shares:106.61M
Float Shares:96.17M
Volume Ratio:0.82
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4234
EPS(LYR):-0.3916
ROE:-21.73%
ROA:-14.18%
PB:0.79
PE(LYR):-3.60

Loading ...

MaxCyte Signs Platform License Agreement With Adicet Bio

THOMSON REUTERS
·
Aug 04

MaxCyte Announces Strategic Platform Licensing Agreement With Anocca Ab to Advance Tcr-T Cell Therapy Pipeline

THOMSON REUTERS
·
Jul 31

MaxCyte Inc. Secures Licensing Deal with Anocca AB to Boost TCR-T Cell Therapy Development

Reuters
·
Jul 31

MaxCyte initiated with an Overweight at Stephens

TIPRANKS
·
Jul 22

MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025

GlobeNewswire
·
Jul 09

BRIEF-MaxCyte Says Nasdaq Listing Unaffected By AIM Delisting - SEC Filing

Reuters
·
Jun 26

MaxCyte Cancels AIM Market Trading for Common Stock

TIPRANKS
·
Jun 26

MaxCyte Inc. Conducted Annual Stockholder Meeting

Reuters
·
Jun 19

MaxCyte Announces Change in Major Holdings by BlackRock

TIPRANKS
·
Jun 12

MaxCyte Inc. and Ori Biotech Announce Strategic Partnership to Enhance Cell Therapy Manufacturing Efficiency

Reuters
·
Jun 11

MaxCyte Announces Change in Voting Rights Structure

TIPRANKS
·
Jun 06

MaxCyte Expands Stock Capital Amidst Strategic Growth

TIPRANKS
·
Jun 03

BlackRock Increases Stake in MaxCyte

TIPRANKS
·
Jun 02

MaxCyte Announces Change in Voting Rights Structure

TIPRANKS
·
May 29

MaxCyte Announces Change in Major Shareholder Voting Rights

TIPRANKS
·
May 23

MaxCyte Announces Change in Major Holdings by BlackRock

TIPRANKS
·
May 23

BlackRock Increases Stake in MaxCyte to 7.65%

TIPRANKS
·
May 20

Stifel Nicolaus Sticks to Its Buy Rating for MaxCyte (MXCT)

TIPRANKS
·
May 08

MaxCyte’s Strategic Growth and Stability: A Buy Rating by Analyst Mark Massaro

TIPRANKS
·
May 08

MaxCyte Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08